Twenty-six significantly enriched pathways for target genes (P < 0.05) mainly involved in “Spliceosome,” “Regulation of actin cytoskeleton,” “Acute myeloid leukemia,” “Transcriptional misregulation in cancers,” “VEGF signaling pathway,” “Lysosome,” “GnRH signaling pathway,” “Systemic lupus erythematosus,” “Endocytosis,” and “Tuberculosis” were screened (Figure 5). This evidence concerns the gene GNRH1 and cancer.